BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36963446)

  • 21. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transition from BOS to RAS impairs prognosis after lung transplantation-CLAD subtype analysis by CT volumetry.
    Peräkylä L; Nykänen A; Piilonen A; Kesävuori R; Halme M; Raivio P
    PLoS One; 2022; 17(10):e0275563. PubMed ID: 36223371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry.
    Fu A; Vasileva A; Hanafi N; Belousova N; Wu J; Rajyam SS; Ryan CM; Hantos Z; Chow CW
    Front Physiol; 2022; 13():980942. PubMed ID: 36277208
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct expression patterns of alveolar "alarmins" in subtypes of chronic lung allograft dysfunction.
    Saito T; Liu M; Binnie M; Sato M; Hwang D; Azad S; Machuca TN; Zamel R; Waddell TK; Cypel M; Keshavjee S
    Am J Transplant; 2014 Jun; 14(6):1425-32. PubMed ID: 24787265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.
    Verleden SE; Ruttens D; Vandermeulen E; van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Vos R
    Transplantation; 2014 Jan; 97(1):83-9. PubMed ID: 24157472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction.
    Pain M; Royer PJ; Loy J; Girardeau A; Tissot A; Lacoste P; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Dahan M; Knoop C; Botturi K; Pison C; Danger R; Brouard S; Magnan A;
    Am J Transplant; 2017 Jun; 17(6):1502-1514. PubMed ID: 27982503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation.
    Itabashi Y; Ravichandran R; Bansal S; Bharat A; Hachem R; Bremner R; Smith M; Mohanakumar T
    Transplantation; 2021 Jun; 105(6):1337-1346. PubMed ID: 32890135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
    Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
    Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of total lymphoid irradiation in different chronic lung allograft dysfunction phenotypes.
    Geng-Cahuayme AAA; Sáez-Giménez B; Altabas-González M; Vázquez-Varela M; Berastegui-Garcia C; Giralt-López de Sagredo J; Zapata-Ortega M; Recalde-Vizcay E; López-Meseguer M
    Clin Transplant; 2023 Feb; 37(2):e14891. PubMed ID: 36583252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
    Verleden GM; Godinas L; Vos R; Verleden SE
    Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
    Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.
    Berastegui C; Gómez-Ollés S; Mendoza-Valderrey A; Pereira-Veiga T; Culebras M; Monforte V; Saez B; López-Meseguer M; Sintes-Permanyer H; Ruiz de Miguel V; Bravo C; Sacanell J; Ramon MA; Romero L; Deu M; Román A
    PLoS One; 2020; 15(1):e0226488. PubMed ID: 31929536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts.
    Pison C; Tissot A; Bernasconi E; Royer PJ; Roux A; Koutsokera A; Coiffard B; Renaud-Picard B; Le Pavec J; Mordant P; Demant X; Villeneuve T; Mornex JF; Nemska S; Frossard N; Brugière O; Siroux V; Marsland BJ; Foureau A; Botturi K; Durand E; Pellet J; Danger R; Auffray C; Brouard S; Nicod L; Magnan A;
    Front Med (Lausanne); 2023; 10():1126697. PubMed ID: 36968829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.